BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36402982)

  • 1. Bone mass density following developmental exposures to perfluoroalkyl substances (PFAS): a longitudinal cohort study.
    Blomberg A; Mortensen J; Weihe P; Grandjean P
    Environ Health; 2022 Nov; 21(1):113. PubMed ID: 36402982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Maternal Serum Perfluoroalkyl Substances Concentrations with Early Adolescent Bone Mineral Content and Density: The Health Outcomes and Measures of the Environment (HOME) Study.
    Buckley JP; Kuiper JR; Lanphear BP; Calafat AM; Cecil KM; Chen A; Xu Y; Yolton K; Kalkwarf HJ; Braun JM
    Environ Health Perspect; 2021 Sep; 129(9):97011. PubMed ID: 34585601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal and early postnatal exposure to perfluoroalkyl substances and bone mineral content and density in the Odense Child Cohort.
    Højsager FD; Sigvaldsen A; Andersen MS; Juul A; Nielsen F; Möller S; Christesen HBT; Grøntved A; Grandjean P; Jensen TK
    Environ Int; 2023 Nov; 181():108264. PubMed ID: 37864903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal and early postnatal exposure to perfluoroalkyl substances and bone mineral content and density in the Odense child cohort.
    Højsager FD; Andersen M; Juul A; Nielsen F; Möller S; Christensen HT; Grøntved A; Grandjean P; Jensen TK
    Environ Int; 2022 Sep; 167():107417. PubMed ID: 35914335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum PFAS and Urinary Phthalate Biomarker Concentrations and Bone Mineral Density in 12-19 Year Olds: 2011-2016 NHANES.
    Carwile JL; Seshasayee SM; Ahrens KA; Hauser R; Driban JB; Rosen CJ; Gordon CM; Fleisch AF
    J Clin Endocrinol Metab; 2022 Jul; 107(8):e3343-e3352. PubMed ID: 35511700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal concentrations of perfluoroalkyl substances and bone health in British girls at age 17.
    Jeddy Z; Tobias JH; Taylor EV; Northstone K; Flanders WD; Hartman TJ
    Arch Osteoporos; 2018 Aug; 13(1):84. PubMed ID: 30076472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-life associations between per- and polyfluoroalkyl substances and serum lipids in a longitudinal birth cohort.
    Blomberg AJ; Shih YH; Messerlian C; Jørgensen LH; Weihe P; Grandjean P
    Environ Res; 2021 Sep; 200():111400. PubMed ID: 34081971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Per- and Polyfluoroalkyl Substance Plasma Concentrations and Bone Mineral Density in Midchildhood: A Cross-Sectional Study (Project Viva, United States).
    Cluett R; Seshasayee SM; Rokoff LB; Rifas-Shiman SL; Ye X; Calafat AM; Gold DR; Coull B; Gordon CM; Rosen CJ; Oken E; Sagiv SK; Fleisch AF
    Environ Health Perspect; 2019 Aug; 127(8):87006. PubMed ID: 31433236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Gestational Perfluoroalkyl Substances Exposure with Early Childhood BMI
    Liu Y; Wosu AC; Fleisch AF; Dunlop AL; Starling AP; Ferrara A; Dabelea D; Oken E; Buckley JP; Chatzi L; Karagas MR; Romano ME; Schantz S; O'Connor TG; Woodruff TJ; Zhu Y; Hamra GB; Braun JM;
    Environ Health Perspect; 2023 Jun; 131(6):67001. PubMed ID: 37283528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to perfluoroalkyl substances and longitudinal changes in bone mineral density in adolescents and young adults: A multi-cohort study.
    Beglarian E; Costello E; Walker DI; Wang H; Alderete TL; Chen Z; Valvi D; Baumert BO; Rock S; Rubbo B; Aung MT; Gilliland FD; Goran MI; Jones DP; McConnell R; Eckel SP; Conti DV; Goodrich JA; Chatzi L
    Environ Res; 2024 Mar; 244():117611. PubMed ID: 38061983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Per- and polyfluoroalkyl substances in umbilical cord serum and body mass index trajectories from birth to age 10 years: Findings from a longitudinal birth cohort (SMBCS).
    Dai Y; Zhang J; Wang Z; Ding J; Xu S; Zhang B; Guo J; Qi X; Chang X; Wu C; Zhou Z
    Environ Int; 2023 Oct; 180():108238. PubMed ID: 37783122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal exposure to per- and polyfluoroalkyl substances and infant growth and adiposity: the Healthy Start Study.
    Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Dabelea D
    Environ Int; 2019 Oct; 131():104983. PubMed ID: 31284113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Per- and polyfluoroalkyl substances and bone mineral content in early adolescence: Modification by diet and physical activity.
    Buckley JP; Zhou J; Marquess KM; Lanphear BP; Cecil KM; Chen A; Sears CG; Xu Y; Yolton K; Kalkwarf HJ; Braun JM; Kuiper JR
    Environ Res; 2024 Jul; 252(Pt 1):118872. PubMed ID: 38580001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of maternal gestational urinary environmental phenols concentrations with bone mineral density among 12-year-old children in the HOME Study.
    Kuiper JR; Pan S; Lanphear BP; Calafat AM; Chen A; Cecil KM; Xu Y; Yolton K; Kalkwarf HJ; Braun JM; Buckley JP
    Int J Hyg Environ Health; 2023 Mar; 248():114104. PubMed ID: 36525700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association between maternal and child PFAS concentrations and repeated measures of ADHD symptoms at age 2½ and 5 years in children from the Odense Child Cohort.
    Dalsager L; Jensen TK; Nielsen F; Grandjean P; Bilenberg N; Andersen HR
    Neurotoxicol Teratol; 2021; 88():107031. PubMed ID: 34563660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to per- and polyfluoroalkyl substances and early childhood adiposity and cardiometabolic health in the Healthy Start study.
    Starling AP; Friedman C; Boyle KE; Adgate JL; Glueck DH; Allshouse WB; Calafat AM; Bloemsma LD; Dabelea D
    Int J Obes (Lond); 2024 Feb; 48(2):276-283. PubMed ID: 38042932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-life exposure to perfluoroalkyl substances in relation to serum adipokines in a longitudinal birth cohort.
    Shih YH; Blomberg AJ; Jørgensen LH; Weihe P; Grandjean P
    Environ Res; 2022 Mar; 204(Pt A):111905. PubMed ID: 34419464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum perfluoroalkyl substances and growth and development in US adolescents: a nationally representative cross-sectional study.
    Wang YF; Zhang XR; Zou YX
    Eur J Pediatr; 2023 Oct; 182(10):4673-4681. PubMed ID: 37561199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated exposure to perfluoroalkyl substances during infancy and serum-adipokine concentrations in later childhood.
    Grandjean P; Shih YH; Jørgensen LH; Nielsen F; Weihe P; Budtz-Jørgensen E
    Pediatr Res; 2023 Nov; 94(5):1832-1837. PubMed ID: 37316707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric Reference Ranges for Ultradistal Radius Bone Density: Results from the Bone Mineral Density in Childhood Study.
    Kindler JM; Kalkwarf HJ; Lappe JM; Gilsanz V; Oberfield S; Shepherd JA; Kelly A; Winer KK; Zemel BS
    J Clin Endocrinol Metab; 2020 Oct; 105(10):e3529-39. PubMed ID: 32561914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.